Proteins Antigenically Related to the Human Erythrocyte Glucose Transporter in Normal and Rous Sarcoma Virus-Transformed Chicken Embryo Fibroblasts. by Salter, Donald W et al.
Dartmouth College
Dartmouth Digital Commons
Open Dartmouth: Faculty Open Access Articles
3-1982
Proteins Antigenically Related to the Human
Erythrocyte Glucose Transporter in Normal and
Rous Sarcoma Virus-Transformed Chicken
Embryo Fibroblasts.
Donald W. Salter
University of Illinois
Stephen A. Baldwin
Dartmouth College
Gustav E. Lienhard
Dartmouth College
Michael J. Weber
University of Illinois
Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa
Part of the Medical Biochemistry Commons, Medical Immunology Commons, and the Medical
Microbiology Commons
This Article is brought to you for free and open access by Dartmouth Digital Commons. It has been accepted for inclusion in Open Dartmouth: Faculty
Open Access Articles by an authorized administrator of Dartmouth Digital Commons. For more information, please contact
dartmouthdigitalcommons@groups.dartmouth.edu.
Recommended Citation
Salter, Donald W.; Baldwin, Stephen A.; Lienhard, Gustav E.; and Weber, Michael J., "Proteins Antigenically Related to the Human
Erythrocyte Glucose Transporter in Normal and Rous Sarcoma Virus-Transformed Chicken Embryo Fibroblasts." (1982). Open
Dartmouth: Faculty Open Access Articles. 1239.
https://digitalcommons.dartmouth.edu/facoa/1239
Proa NatL Acad. Sci. USA
Vol. 79, pp. 1540-1544, March 1982
Cell Biology
Proteins antigenically related to the human erythrocyte glucose
transporter in normal and Rous sarcoma virus-transformed
chicken embryo fibroblasts
(membrane alterations/malignant transformation)
DONALD W. SALTER*t, STEPHEN A. BALDWIN0, GUSTAV E. LIENHARDt, AND MICHAEL J. WEBER*
*Department of Microbiology, University of Illinois, Urbana, Illinois 61801; and tDepartment of Biochemistry, Dartmouth Medical School, Hanover,
New Hampshire 03755
Communicated by C. Ladd Prosser, November 30, 1981
ABSTRACT Antibody raised against the purified human
erythrocyte glucose transporter specifically precipitated four pro-
teins from normal and Rous sarcoma virus-transformed chicken
embryo -cells: a major protein of Mr 41,000 and minor proteins of
Mr 68,000, 73,000, and 82,000. The Mr41,000 and 82,0 proteins
were found only in a membrane fraction, not in the soluble frac-
tion, and displayed a heterogeneous mobility on NaDodSOd
polyacrylamide gel electrophoresis, suggesting glycosylation. The
Mr 41,000 and 82,000 proteins were increased in amount after
malignant transformation in direct proportion to the increase in
hexose transport rate, and the increase was dependent on the
expression of the src gene product, as revealed with a tempera-
ture-conditional src mutant. We suggest that the Mr 41,000 and
82,000 proteins are the glucose transporter of chicken embryo fi-
broblasts, or a component of the glucose transporter. These ex-
periments provide .direct evidence that malignant transformation
increases the rate of glucose transport by increasing the number
of transporters in the membrane.
Malignant transformation of chicken embryo cells by Rous sar-
coma virus (RSV) causes a striking increase in the rate at which
these cells transport glucose across the cell membrane (1-4).
Despite much research, little is known about the molecular
basis for this alteration. It is clear that the activity of the viral
transforming protein pp6Osrc is essential for the increase in glu-
cose transport because viral mutants coding for a temperature-
sensitive pp6Osrc are temperature-sensitive in their ability to
increase the transport rate (5, 6). Inhibitor data suggest that the
increased transport rate requires new protein synthesis but not
new RNA synthesis (6, 7). Induction of the increased, transport
requires a functional nucleus (8). The mechanism by which
pp60src causes this increase in transport rate is completely
unknown.
In theory, it seems possible that pp6osrc could act (i) to in-
crease the number ofnormal cellular transporters, (ii) to induce
the synthesis of a new class of transporters, or (iii) to increase
the activity of preexisting transporters. The fact that transfor-
mation results in an increase in the maximal velocity for trans-
port but does not detectably change the half-saturation constant
(2, 3) has been -used to argue for-the first hypothesis-namely,
that transformation causes an increase in the number of normal
carriers. However, this argument is a weak one because cases
are known in which allosteric regulation causes an increase in
the maximal velocity without affecting the half-saturation con-
stant for substrate. (9). Recently, Salter and Weber (10) dem-
onstrated that a portion of the binding of cytochalasin B to
chicken embryo cells could be stereospecifically inhibited by
D-glucose, and this "glucose-specific" cytochalasin B binding
was increased in transformed cells which displayed a high hex-
ose transport rate. Because it had been shown that the purified
glucose transporter from human erythrocytes bound cytochal-
asin B (11, 12), this result provided strong, but still indirect,
evidence for the suggestion that transformed cells contain in-
creased numbers of glucose transporters in their membranes.
In addition to their cytochalasin binding properties the
chicken embryo cell glucose transporter and the human eryth-
rocyte glucose transporter share the following-features: both are
facilitated diffusion systems (2, 13) and, to the extent that sub-
strate specificity has been determined, both have similar spec-
ificities (2, 14). These similarities suggested to us the possibility
that the two proteins might have some antigenic similarities.
Since Baldwin and Lienhard (14) recently characterized an anti-
serum prepared against the purified human erythrocyte trans-
porter, it became possible to determine whether immunolog-
ically crossreactive proteins could be found in chicken embryo
cell membranes and whether these proteins increased in
amount during malignant transformation. While this work was
in progress, Sogin and Hinkle (15) reported immunological
crossreactivity between the human erythrocyte transporter and
proteins of cultured mammalian cells. We have found proteins
in chicken embryo cells that appear to be antigenically related
to the human erythrocyte glucose transporter. Two of these
proteins are probably glycosylated, are found in a crude mem-
brane fraction, and increase in approximately direct proportion
to the. glucose transport rate upon transformation.
MATERIALS AND METHODS
Virus Strains. The Schmidt-Ruppin strain ofRSV subgroup
A (SR-RSV) and its temperature-conditional mutant counter-
part, tsNY68, were obtained originally from S. Kawai and H.
Hanafusa (Rockefeller. University) (6).
Sera. The preparation of preimmune serum (about 6 mg of
IgG per ml) and antiserum against the human erythrocyte glu-
cose transporter (about 13 mg ofIgG per ml) has been described
(14). Normal rabbit serum was prepared from an unrelated,
unimmunized rabbit.
Other Materials. [35S]Methionine, [32P]phosphate, and
EN3HANCE were obtained from New England Nuclear. Pro-
tein A-Sepharose was obtained from Sigma. The human eryth-
rocyte glucose transporter was purified in the presence of the
detergent octaethylene glycol n-dodecyl ether and reconstituted
with additional dioleoylphosphatidylcholine as described (16).
The preparations contained 118. ,g of protein and 3.5 jig of
Abbreviations: RSV, Rous sarcoma virus; SR, Schmidt-Ruppin strain.
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phospholipid per ml. All other chemicals were of reagent grade
or higher quality.
Cells and Cell Culture. Fibroblasts were obtained from 11-
day gs-/chf- chicken embryos (Spafas, Norwich, CT) and cul-
tured as described (2). Secondary cell cultures were infected
with SR-RSV (subgroup A) or tsNY68 and maintained at 40'C
or 420C, respectively; uninfected cells were maintained at 40'C.
Prior to radiolabeling, tertiary cell cultures were plated at 1.8
X 106, 1.4 X 106, and 1.1 x 106 cells per 100-mm dish (Corning)
for SR-RSV, tsNY68, and normal cells, respectively, and in-
cubated at the temperature indicated above. Because of differ-
ences in the efficiency ofattachment, this provides cell cultures
with similar densities. In addition, the use ofmedium with high
glucose and the protocol of medium changes (see below) were
sufficient to prevent glucose depletion.
Radiolabeling and Preparation of Cell Fractions. For
[3S]methionine labeling, 30 hr after subculture, the medium
was changed to medium containing 4% calf serum, 1% heat-in-
activated chicken serum, and only 0.01 mM nonradioactive L-
methionine plus [3S]methionine (150-300 gCi/100-mm dish;
1 Ci = 3.7 x 1010 becquerels). For [32P]phosphate labeling, the
medium was changed to phosphate-free medium containing 4%
calf serum, 1% heat-inactivated chicken serum, and isotope at
500 ,uCi/100-mm dish. One tsNY68-infected culture was then
shifted to the permissive temperature (360C), and the cultures
were then incubated for approximately 24 hr. Particulate and
soluble fractions were prepared from the radiolabeled cells by
the method ofEsko et aL (17). In a typical cell fractionation, 22%
and 27% of the total cell protein was found in the particulate
fraction from transformed and normal cells, respectively. Sim-
ilar values were obtained with tsNY68-infected cells labeled at
the permissive or nonpermissive temperature.
The trichloroacetic acid-insoluble [3S]methionine-labeled
proteins of the soluble and particulate fractions had approxi-
mately the same specific activities, 1 x 105 and 1.2 X 105 cpm/
pug of protein, respectively.
Preparation of Extracts. The particulate fraction was ex-
tracted with radioimmunoprecipitation assay lysis buffer (18)
(50 mM Tris HCl, pH 7.5/150 mM NaCl/1% Nonidet P-40/
1% sodium deoxycholate/0. 1% sodium dodecyl sulfate) con-
taining 100 units ofTrasylol (FBA Pharmaceuticals) at a protein
concentation of approximately 0.18 ,g/,l. Samples were in-
cubated for 2 hr at 4°C with intermittent mixing and then cen-
trifuged for 15 min in an Eppendorf Microfuge at 12,500 X g;
the pellet was discarded. An extract of purified glucose trans-
porter was similarly prepared. In a typical experiment, 44%,
75%, 74%, and 75% of the [3S]methionine-labeled proteins
were extracted from the particulate fractions ofnormal cells, SR-
RSV-infected cells, tsNY68-infected cells at 36°C, and tsNY68-
infected cells at 420C, respectively. The apparent low value for
normal cells appeared to be due to a larger amount of radiola-
beled fibronectin present in the particulate fraction of normal
cells in comparison to the other cells. Polyacrylamide gel elec-
trophoresis revealed that little or no fibronectin was solubilized
under these conditions but that there was no preferential ex-
traction ofany other major proteins between the cell types (data
not shown).
Immunoprecipitation. Extracts were incubated with anti-
serum and the antigen-antibody complexes formed were col-
lected by binding to protein A-Sepharose. In a typical experi-
ment, 125-150 A1l of radiolabeled extract, containing 18-22 ,g
of particulate proteins, was incubated with either 5 or 10 ,ul of
unblocked or blocked antiserum or 10 Al ofpreimmune serum.
Control experiments demonstrated that antiserum was in ex-
cess. Blocked antiserum was prepared by preincubating 30 Al
of solubilized, purified glucose transporter (1.8 ug of protein
and 53 ,g of phospholipid) with the antiserum for 15 min prior
to the addition of labeled extracts. Protein A-Sepharose was
prepared by rehydrating 70 mg in 1 ml of water overnight and
resuspending in 1 ml of 0.05% Nonidet P-40/150 mM NaCl/
5 mM EDTA/50 mM Tris, pH 7.5. An excess (50 gl) of this
slurry was then added to collect the antigen-antibody com-
plexes. Incubation was continued for 1 hr at 40C with inter-
mittent mixing. The protein A-Sepharose-antibody-antigen
complex was centrifuged for 2 min in the Microfuge, and the
pellet was washed seven times with 600 ul of lysis buffer and
once with 10 mM Tris-HCl (pH 7.5) at 40C. Samples were re-
suspended and then boiled to dissociate the antigen-antibody
complex.
Samples were then electrophoresed (19) and, for [3S]meth-
ionine-labeled extracts, fluorographed with EN3HANCE
(20). Under these conditions (with preflashed film), the amount
of radioactivity in a band is approximately proportional to band
intensity. Thus, quantification was performed by scanning au-
toradiograms with an Ortec model 4310 scanning densitometer.
Electropherograms of [32P]phosphate-labeled extracts were au-
toradiographed with an intensifying screen (Dupont Lightning
Plus) and exposure at -700C for 5 days.
RESULTS
Crossreactive Proteins in Normal and Transformed Cells.
Fig. 1 shows results obtained when the [3S]methionine-labeled
particulate fraction from transformed and normal chicken fi-
broblasts was extracted with lysis buffer and the extract was im-
munoprecipitated with antiserum prepared against the purified
glucose transporter from human erythrocytes. In both trans-
formed and normal cells, there were three proteins-Mr
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FIG. 1. Gel electropherogram of immunoprecipitates of particu-
late fractions. SR, transformed cells; N, normal cells. Lanes: a, immune
serum, 5 sl; b, immune serum, 10 1l; c, immune serum, 10 IL, plus
purified erythrocyte glucose transporter; d, immune serum, 10 IL, plus
bovine serum albumin; e, normal rabbit serum, 10 ILI; f, preimmune
rabbit serum, 10 Al. The large number of nonspecific bands is often
obtained in immunoprecipitates from the particulate fraction. Mr of
standards are shown x 10'.
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41,000, 73,000, and 82,000-that were immunoprecipitated by
the immune serum (lanes a, b, and d) but not by normal rabbit
serum (lane e) or preimmune serum (lane f). In addition, the
immunoprecipitation of these three bands was blocked by pu-
rified glucose transporter plus phospholipid (lane c) but not by
an equivalent amount of bovine serum albumin and phospho-
lipid (lane d). Two of the proteins (Mr 41,000 and 82,000) ran
as broad bands in the gels; this behavior indicates heteroge-
neity, which in other cases has been found to be due to het-
erogeneous glycosylation (21, 22). The Mr 73,000 protein elec-
trophoresed as a sharper band. Visual inspection of the
chromatogram revealed that the Mr 41,000 and 82,000 bands
were in much higher amount in transformed cells than in normal
cells (compare lanes a, b, and d within each cell type).
Cells Infected with a Temperature-Conditional src Mutant.
Infection of chicken embryo cells by RSV results not only in
malignant transformation but also in virus production. It is thus
conceivable that the data shown in Fig. 1, which indicate a virus-
induced increase in the production of proteins antigenically re-
lated to the human erythrocyte glucose transporter, are the
consequence ofvirus replication rather than transformation. To
distinguish between these possibilities, we made use oftsNY68,
a mutant coding for a temperature-sensitive pp6src. Cells in-
fected with tsNY68 produce high titers ofinfectious virus at both
360C and at 420C but display the transformed phenotype only
at 36°C (the permissive temperature) (6).
Fig. 2 demonstrates that the increased levels ofcrossreactive
proteins depend on the activity ofpp6(Yrc. As in Fig. 1, proteins
Of Mr 41,000, 73,000, and 82,000 were immunoprecipitated by
immune serum (lanes a, b, and d) but not by normal rabbit
serum (lane e) or preimmune serum (lane f). Immunoprecipi-
tation of these three bands was blocked when purified glucose
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transporter and phospholipid were included in the reaction
mixture (lane c); an equivalent amount ofbovine serum albumin
and phospholipid had little effect on the immunoprecipitation
of these three proteins (lane d). Visual inspection reveals in-
creased amounts of the crossreactive proteins in cells grown at
36°C (the permissive temperature) compared to cells grown at
42°C (the restrictive temperature).
Quantitation of Crossreactive Proteins. Table 1 summarizes
the results of the quantitation of the amount of each of these
three bands in the four different cell types. The data have been
normalized to the value found in normal cells. The amounts of
the Mr 41,000 and 82,000 proteins were significantly increased
in cells transformed by the wild-type SR-RSV and in tsNY68-
infected cells labeled at the permissive temperature; tsNY68-
infected cells labeled at the nonpermissive temperature had the
amount of these two protein bands characteristic of normal,
uninfected cells. The Mr 73,000 protein band appeared to be
only slightly increased in the transformed cells; the significance
of this difference is not known.
The transformation-specific difference in the levels of the Mr
41,000 and 82,000 proteins was comparable to the differences
in transport rate generally shown by these cell types when the
cells were cultured under identical conditions. The uptake of
2-deoxyglucose (nmol/mg of protein per 15 min) was: normal
cells, 11; transformed cells, 32; tsNY68-infected cells, 5 and 25
at 42°C and 36°C, respectively.
Crossreactive Proteins in the Soluble Fraction. We also ex-
amined the soluble protein fraction for proteins specifically pre-
cipitated by the immune serum (Fig. 3). The Mr 41,000, 73,000,
and 82,000 proteins were not specifically immunoprecipitated
from the soluble portion of the lysed cells. However, small
amounts of a protein of Mr -65,000 were precipitated by the
immune serum, blocked by purified glucose transporter, and
not precipitated with either preimmune serum or normal rabbit
serumn. It appeared that the amount of this protein was not
greatly increased in transformed cells and it was present in
much lesser amount than the three protein bands associated
with the particulate fraction.
It is noteworthy that the preimmune serum precipitated sev-
eral chicken proteins not precipitated by normal rabbit serum
(serum from an unrelated, unimmunized rabbit) (compare lanes
e and f in Figs. 1 and 2). In particular, a protein of Mr 68,000
was specifically precipitated by the preimmune serum. Im-
mune serum from the same rabbit did not precipitate this pro-
tein as strongly as did the preimmune serum at the same or
higher IgG concentration (lanes a and b, Figs. 1 and 2). This
protein band was not blocked with erythrocyte membrane ex-
tracts (data not shown) and thus appears to be antigenically un-
related to the glucose transporter. The amount of this protein
did not change with transformation. A protein with a similar Mr
was precipitated from the soluble protein fraction by preim-
mune serum (Fig. 3). These surprising data may be a conse-
quence of serendipitous crossreaction between certain chicken
cell proteins and the natural antibodies of the rabbit used for
-26
FIG. 2. Gel electropherogram of immunoprecipitates of particu-
late fractions from cells infected with the temperature-conditional
mutant tsNY68 and held at either the permissive (36°C) or nonper-
missive (42°C) temperature. Lanes: a, immune serum, 5 ILI; b, immune
serum, 10 Al; c, immune serum, 10 IlI, plus purified erythrocyte trans-
porter; d, immune serum, 10 pl, plus bovine serum albumin; e, normal
rabbit serum, 10 ,ul; f, preimmune serum, 10 ul.
Table 1. Relative amounts of proteins immunoprecipitated by
anti-erythrocyte glucose transporter
Protein Ratio:
band, transformed/ tsNY6&ifected cells
Mr normal 420C 360C
41,000 3.7 ± 1.0 0.8 ± 0.1 2.7 ± 1.0
73,000 1.5 ± 0.7 0.8 ± 0.3 1.4 ± 0.7
82,000 5.6 ± 2.5 0.9 ± 0.2 3.8 ± 1.5
Results are shown as mean ± SD of five independent determinations
on the same extract.
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FIG. 3. Gel electropherogram of immunoprecipitates of soluble
fractions from normal and transformed cells. SR, wild-type trans-
formed cells; N, normal cells; tsNY68, infected cells at either permis-
sive (36QC or restrictive (4200) temperature. Lanes: a, immune serum,
10,1.d b, immune serum plus purified erythrocyte transporter; c, preim-
mune serum; d, normal rabbit serum.
immunization. We recently prepared another antiserum against
a different preparation of the human erythrocyte transporter.
This antiserum also precipitated proteins Of Mr "41,000 and
;:=82,000 but the preimmune serum from this rabbit did not
precipitate the Mr 68,000 protein.
Crossreactive Proteins Are Not Phosphorylated. Because
pp6O'r is a protein kinase (23, 24), we wished to investigate the
possible phosphorylation of the three particulate proteins spe-
cifically precipitated by antiserum against the human erythro-
cyte transporter. fP-Labeledparticulate fractions from normal
and transformed cells were extracted with lysis buffer and pre-
cipitated with immune serum. No additional phosphorylated
proteins were immunoprecipitated with immune serum when
compared to preimmune serum under conditions such that the
phosphorylatedpp6t00cprotein could easily be detected (25)
(data not shown).
DISCUSSION
We have used antisera raised against the purified human eryth-
rocyte transporter to detect immunologically crossreactive pro-
teins in normal and transformed chicken embryo fibroblasts.
When we began these experiments, we were concerned that,
even though the human and the chicken transporter were func-
tionally similar, the evolutionary distance between the chicken
and the human was so great that we would not detect immu-
nological crossreaction. Our results presented the opposite
problem: not one but four immunologically crossreactive bands.
Because one protein has an apparent Mr double that of the Mr
41,000 protein and because both are coregulated, found in
crude membranes, and appear to be glycosylated, we suspect
that the Mr 82,000 protein is a dimer of the Mr 41,000 protein.
About 20% ofthe protein in preparations ofpurified erythrocyte
glucose transporter [which has a Mr of about 45,000 for the
monomer (11, 22)] often runs in the dimer region upon
NaDodSO4/polyacrylamide gel electrophoresis (ref. 11; un-
published data). The Mr 65,000 protein found in the soluble
fraction of the cell, and the Mr 73,000 protein found with the
membrane fraction could be precursors to, proteolytic frag-
ments of, or unrelated to the Mr 41,000 and 82,000 proteins.
The fact that the amount of these proteins appears not to vary
greatly with transformation argues (albeit, weakly) against the
first two possibilities.
We believe that theMA41,000 and 82,000 protein bands rep-
resent the chicken fibroblast glucose transporter or a compo-
nent ofthe transporter, for the following reasons. (a) These pro-
teins could be precipitated by antisera raised against the human
erythrocyte transporter but not by preimmune or normal sera.
(b) The immunoprecipitation was blocked by purified eryth-
rocyte transporter or by human erythrocyte ghosts; the precip-
itation was not blocked by bovine erythrocyte ghosts, which do
not possess a cytochalasin-sensitive glucose transport system
(unpublished data). (c) The proteins were found in the mem-
brane fraction of the cells and appeared to be glycosylated. (d)
The amount ofMr 41,000 and 82,000 proteins varied upon trans-
formation in direct proportion to the hexose transport rate of
the cells. (e) The amount of these proteins is comparable to the
amount of glucose-specific cytochalasin B binding displayed by
these cells (see below).
The following calculation indicates that the Mr 41,000 and
82,000 proteins are present in transformed cell membranes in
amounts consistent with their being the glucose transporter.
We previously found (10) that, when cytochalasin B was incu-
bated with the particulate fraction from transformed cells at a
concentration near its apparent dissociation constant, 31.6 pmol
of cytochalasin B was bound per mg of protein to a glucose-in-
hibitable site. This value converts to approximately 60 pmol of
"glucose-specific" cytochalasin B sites per mg of protein at sat-
uration. In the experiments reported here, we obtained ap-
proximately 1800 cpm in the Mr 41,000 plus Mr 82,000 bands
from the particulate fraction of transformed cells. The specific
activity of the total cellular proteins was 81,500 cpm/4g of pro-
tein in these experiments, which corresponds to 0.02 Ag ofpro-
tein in the putative transporters. Because 18.5 ,ug ofprotein was
used in the immunoprecipitation, there were approximately 1.1
,tg of the Mr 41,000 and 82,000 proteins per mg of total protein
in the particulate fraction. Taking 41,000 as the monomer Mr
and assuming a methionine content in the transporter equiva-
lent to that found in the total cell protein, we calculate that there
were 27 pmol oftransporter per mg ofprotein in the particulate
fraction. Considering the assumptions involved in these cal-
culations, and the possibilities for experimental error, we think
that this value is remarkably close to the value, 60 pmol/mg,
obtained from the cytochalasin B measurements.
Although we believe that our antisera recognize the glucose
transporter ofchicken embryo cells, we have been unsuccessful
in attempts to immunoprecipitate D-glucose-inhibitable cyto-
chalasin B binding activity from an octyl glucoside extract of
transformed cells. We suspect that this is due to inefficient pre-
cipitation of the crossreactive proteins from the detergent ex-
tract. Nonetheless, these negative results point out both the
difficulty and the importance of determining unambiguously
the functional identity of the crossreactive proteins.
The transformation-related increase in the Mr 41,000 and
82,000 proteins is dependent on the activity of pp6Osrc because
cells infected with a temperature-conditional mutant of RSV
displayed the increase only at the permissive temperature. Be-
cause pp6OrC has been shown to be a protein kinase, it was of
interest to determine whether the putative transporters were
phosphorylated. We were unable to detect phosphorylation of
any of the proteins specifically precipitated by our antiserum,
under conditions in which we can readily detect phosphoryla-
tion of pp60rC itself (25). Because the transporter and pp6(Y"'
are present in cells in similar amounts (see above and ref. 26)
we think that this negative result is significant. Thus, it seems
unlikely that the glucose transporter is a primary target of
pp60swrc.
Cell Biology: Salter et aL
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Our data strongly suggest that the transformation-related in-
crease in glucose transport rate is due to an increased number
of normal cellular transporters. Because the Mr of the putative
transporter is the same in normal and transformed cells and
because our previous studies have not revealed changes in
transport kinetics, specificity, or sensitivity to inhibitors (2, 10),
neither a new transport system (27) nor allosteric effects are
likely to play major roles in increasing the glucose transport rate
in transformed cells.
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